Clinical Trial

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants With Smooth Surface

Study acronym: STEPS S
Recruiting
View on ClinicalTrials.gov →
Summary
The study investigates the safety and performance of Silimed® brand smooth surface breast implants in women born with indication for primary and secondary (revision) augmentation to be followed up for 10 years. The safety of the smooth-surfaced Silimed® implant will be evaluated by estimating known and unexpected short-term and long-term risk/adverse event rates through patient reports of adverse events after implantation. The performance of using Silimed® brand smooth surface breast implants will be evaluated by evaluating satisfaction and quality of life after implantation.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-04-20; most recent amendment 2026-03-12.
Status change: Not Yet Recruiting → Recruiting 2022-10-31
Trial Details
NCT Number NCT05345821
Lead Sponsor Silimed Industria de Implantes Ltda
Collaborators: Centro Universitário Saúde ABC
Conditions Breast Implant; Complications, Quality of Life, Satisfaction, Safety and Performance
Enrollment 384 participants
Start Date 2022-10-05
Primary Completion 2036-08 (estimated)
Study Completion 2036-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-16